norovirus
nov
caus
sporad
acut
nonbacteri
gastroenter
age
group
nov
divid
five
genogroup
gi
gv
gi
gii
strain
mostli
affect
human
recent
nov
genotyp
respons
major
sporad
gastroenter
case
outbreak
nov
genom
consist
singlestrand
rna
kb
organ
open
read
frame
orf
code
rnadepend
rna
polymeras
encod
two
structur
protein
express
capsid
gene
recombin
baculovirus
lead
selfassembl
empti
viruslik
particl
vlp
morpholog
antigen
similar
nativ
nov
nov
vlp
wide
use
antigen
diagnost
serolog
assay
candid
vaccin
nov
nov
vlp
highli
stabl
resist
variabl
condit
particularli
low
ph
limit
nov
vlp
product
term
inadequ
yield
qualiti
vlp
sucros
cscl
gradient
ultracentrifug
use
purif
nov
vlp
even
though
studi
rotaviruslik
particl
demonstr
low
yield
impur
result
cscl
gradient
purif
present
studi
compar
commonli
use
method
nov
vlp
purif
concentr
consid
puriti
yield
morpholog
integr
antigen
function
purifi
vlp
step
clone
nov
genbank
sequenc
databas
access
number
fulllength
capsid
gene
describ
elsewher
vlp
produc
insect
cell
infect
recombin
baculoviru
accord
manufactur
instruct
invitrogen
carlsbad
ca
baculoviru
titer
express
multipl
infect
moi
stock
determin
use
bacpak
rapid
titer
kit
clontech
laboratori
mountain
view
ca
day
infect
cell
cultur
ml
clarifi
centrifug
min
vlp
supernat
concentr
ultracentrifug
ultracentrifug
beckman
ti
rotor
h
pellet
resuspend
ph
vlp
load
onto
discontinu
sucros
gradient
ultracentrifug
h
describ
fraction
collect
bottom
punctur
fraction
contain
vlp
pool
addit
discontinu
sucros
gradient
ultracentrifug
perform
sucros
remov
overnight
dialysi
liter
pb
vlp
concentr
dialysi
polyethylen
glycol
peg
ultrafiltr
vlp
concentr
use
amicon
ultra
kda
centrifug
filter
devic
millipor
corpor
billerica
germani
vlp
store
pb
altern
less
timeconsum
sucros
densiti
gradient
purif
method
employ
clarifi
supernat
pellet
twice
ultracentrifug
pellet
resuspend
ph
place
discontinu
sucros
densiti
gradient
ultracentrifug
h
vlp
band
visibl
sucros
layer
collect
sucros
remov
dialysi
liter
pb
vlp
concentr
ultracentrifug
h
addit
clarifi
supernat
concentr
pellet
resuspend
steril
water
vlp
sediment
ultracentrifug
cesium
chlorid
cscl
gml
h
describ
earlier
other
cscl
remov
dialysi
pb
vlp
concentr
use
amicon
ultrafilt
total
protein
content
purifi
vlp
prepar
determin
use
pierc
bca
protein
assay
thermo
scienc
rockford
usa
endotoxin
level
vlp
prepar
quantifi
use
limulu
amebocyt
lysat
lal
assay
lonza
walkersvil
md
usa
level
endotoxin
protein
intern
standard
protein
sampl
analyz
protein
express
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
presenc
nov
vlp
verifi
electron
microscopi
em
vlp
prepar
neg
stain
uranyl
acet
ua
ph
vlp
examin
use
fei
tecnai
electron
microscop
oper
kv
bind
vlp
carbohydr
receptor
examin
histoblood
group
antigen
hbga
bind
assay
describ
other
slight
modif
briefli
vlp
coat
ngwell
synthet
biotinyl
h
type
lewisb
histoblood
group
carbohydr
lectin
hold
inc
moscow
russia
use
serial
threefold
dilut
start
well
lack
synthet
carbohydr
use
neg
control
condit
cell
infect
optim
order
obtain
high
yield
vlp
recombin
baculoviru
stock
moi
found
optim
vlp
harvest
supernat
day
infect
vlp
purifi
sever
differ
procedur
describ
fig
best
yield
ml
obtain
purif
procedur
describ
fig
panel
b
comparison
method
describ
fig
panel
c
yield
ten
time
lower
amount
nov
capsid
vlp
puriti
vlp
obtain
method
determin
sdspage
stain
protein
pageblu
fig
total
protein
load
lane
method
result
equal
pure
protein
band
correspond
size
nov
capsid
residu
peg
present
vlp
concentr
peg
dialysi
may
interf
protein
concentr
determin
could
explain
lower
capsid
protein
concentr
observ
fig
lane
nov
capsid
ident
antigen
vlp
assay
western
blot
use
human
novspecif
convalesc
sera
fig
result
show
pure
nov
capsid
protein
without
degrad
similar
antigen
purif
method
next
determin
morpholog
integr
homogen
vlp
em
fig
vlp
obtain
purif
sucros
densiti
gradient
follow
dialysi
either
ultrafiltr
fig
panel
b
ultracentrifug
fig
panel
c
approxim
nm
size
classic
appear
nov
capsid
vlp
contrast
cscl
purif
fig
panel
concentr
vlp
dialysi
peg
fig
panel
result
vlp
heterogen
size
appear
broken
aggreg
vlp
purifi
concentr
method
schemat
present
fig
panel
b
best
qualiti
subject
analysi
determin
optim
storag
condit
stabil
nov
capsid
vlp
vlp
treat
differ
condit
sampl
analyz
sdspage
test
protein
integr
fig
em
examin
morpholog
fig
vlp
stabl
least
month
pb
ph
fig
b
panel
room
temperatur
day
fig
b
panel
vlp
withstood
steril
filtrat
condit
filter
durapor
millipor
ireland
use
next
intent
disrupt
vlp
morpholog
heat
treatment
h
fig
panel
without
degrad
capsid
protein
fig
lane
hbga
bind
assay
use
test
function
purifi
vlp
well
determin
signific
conform
bind
site
vlp
would
presum
requir
intact
vlp
comparison
bind
vlp
purifi
sucros
gradient
centrifug
cscl
sediment
well
heattreat
vlp
h
synthet
biotinyl
h
type
carbohydr
shown
fig
bind
clearli
depend
morpholog
preserv
structur
vlp
lowest
level
bind
observ
heattreat
vlp
disrupt
conform
bind
site
lewisb
antigen
use
control
assay
bind
vlp
fig
nov
vlp
use
extens
studi
protein
interact
viru
assembl
use
tool
diagnost
serolog
assay
clinic
trial
perform
nov
vlp
use
vaccin
applic
highqual
vlp
would
prefer
studi
differ
method
vlp
purif
concentr
use
puriti
integr
morpholog
antigen
function
nov
vlp
prepar
examin
vlp
purifi
method
fig
method
similar
appear
migrat
pattern
sdspage
gel
western
blot
human
convalesc
serum
individu
infect
confirm
ident
capsid
lack
degrad
product
reason
lower
protein
yield
purif
procedur
c
might
narrow
visibl
band
vlp
collect
sucros
caus
protein
omit
thu
affect
yield
howev
yield
mg
vlp
obtain
best
purif
method
describ
present
studi
remark
high
compar
report
em
analysi
morpholog
integr
homogen
vlp
show
vlp
obtain
purif
sucros
densiti
gradient
follow
ultrafiltr
ultracentrifug
procedur
b
c
respect
homogen
intact
approxim
nm
size
howev
csclpurifi
vlp
appear
heterogen
size
broken
particl
although
compar
morpholog
seen
other
cscl
purif
known
introduc
sever
impur
end
process
caus
aggreg
vlp
storag
poorest
morpholog
seen
concentr
vlp
dialysi
peg
result
aggreg
addit
residu
peg
leak
dialysi
membran
might
interfer
applic
vlp
data
clearli
demonstr
purif
process
affect
integr
nativ
quaternari
structur
nov
vlp
subsequ
receptorbind
function
vlp
although
major
vlp
purifi
cscl
method
seem
intact
em
imag
differ
sucrosedensitygradientpurifi
vlp
hbga
bind
strike
result
support
recent
find
cscl
neg
impact
function
vlp
also
demonstr
even
heatdisrupt
vlp
bind
capabl
intact
homogen
vlp
significantli
greater
bind
intens
standard
purif
method
nov
vlp
use
diagnost
serolog
assay
block
assay
would
greatli
strengthen
result
obtain
best
knowledg
first
time
vlp
purifi
convent
purif
concentr
method
compar
term
yield
puriti
morpholog
integr
antigen
function
result
show
nov
vlp
purifi
twice
sucros
densiti
gradient
centrifug
follow
ultrafiltr
maintain
icosahedr
capsid
structur
capac
bind
hbga
